← Eichor
Condition: Anca Associated Vasculitis Aav Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anca Associated Vasculitis Aav

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
Phase 1 · 2 location(s) · Beijing GoBroad Hospital · NCT06980597Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07315087BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Phase 3 · 65 location(s) · Staidson (Beijing) Biopharmaceuticals Co., Ltd · NCT07168161CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07305116CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06941129Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06614270Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Phase 2 · 35 location(s) · Novartis Pharmaceuticals · NCT06868290Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Phase 4 · 22 location(s) · Chiba University · NCT06611696MTS109 in Patients With Refractory Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT07526350Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
EARLY_Phase 1 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT07507201Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1/Phase 2 · 3 location(s) · Cartesian Therapeutics · NCT07089121Rare AutoImmune SElf-management Programme Development
Phase N/A · 1 location(s) · University of the West of England · NCT06642870Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Phase N/A · 1 location(s) · University of Bonn · NCT07150000A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Phase 1/Phase 2 · 17 location(s) · Nkarta, Inc. · NCT06733935Multicenter Cohort Study of AAV in Hunan of China
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT05315141AYLo - AutoimmunitY and Loss of y
Phase N/A · 1 location(s) · University of Bonn · NCT06696027A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Phase 4 · 83 location(s) · Amgen · NCT06072482Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Nanjing Bioheng Biotech Co., Ltd. · NCT06775912A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · 21 location(s) · Fate Therapeutics · NCT06308978PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis
Phase N/A · 1 location(s) · University of Edinburgh · NCT07258524
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.